We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

HHS Slams FDA Over Conflict-Of-Interest Monitoring

Law360 (January 12, 2009, 12:00 AM EST) -- The U.S. Food and Drug Administration has fallen behind in tracking potential financial conflicts of interest between medical professionals who conduct clinical trials and the pharmaceutical companies that sponsor them, according to a new study released by the U.S. Department of Health and Human Services.

On Monday, the HHS published the results of its look into the FDA's oversight of clinical investigators' financial information, revealing that only 1 percent of investigators have disclosed a financial interest.

The study also revealed that an estimated 42 percent of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.